Molecular genetic evidence for subtypes of oligoastrocytomas

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 10, 1997, Pages 1098-1104

  Maintz, David ^a   Fiedler, Klaus ^a   Koopmann, Jens ^a   Rollbrocker, Britta ^a   Nechev, Stefan ^a   Lenartz, Doris ^b   Stangl, Armin P ^a   Louis, David N ^c   Schramm, Johannes ^a   Wiestler, Otmar D ^a   Von Deimling, Andreas ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b KRANKENHAUS MERHEIM   (Germany)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Allelic Loss; Astrocytoma; LOH; Mutation; Oligoastrocytoma; Oligodendroglioma; TP53

Indexed keywords

DNA;

ARTICLE; ASTROCYTOMA; CHROMOSOME 17P; CHROMOSOME 19Q; CHROMOSOME 1P; CONTROLLED STUDY; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MOLECULAR GENETICS; OLIGODENDROGLIOMA; PRIORITY JOURNAL;

EID: 0030883778     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199710000-00003     Document Type: Article

References (21)

1. Kleihues P, Burger PC, Scheithauer BW, Histological typing of tumours of the central nervous system, 2nd edition, New York, Springer-Verlag Berlin, 1993
2. Kim L, Hochberg FH, Thornton AF, et al. Procarbazine, iomustine, and vincristine (PVC) chemotherapy for grade III and grade IV oligoastrocytomas. J Neurosurg 1996;85:602-7
3. Louis DN, Gusella JF. A tiger behind many doors: Multiple genetic pathways to malignant glioma. Trends Genet 1995;11:412-15
4. von Deimling A, Louis DN, Wiestier OD. Molecular pathways in the formation of gliomas. Glia 1995;15:328-38
5. von Deimling A, Eibl RH, Ohgaki H, et al. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res 1992;52:2987-90
6. Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM. p53 mutation and loss of heterozygosity on chromosome 17 and 10 during human astrocytoma progression. Cancer Res 1992;52:674-79
7. Saxena A, Clark WC, Robertson JT, Ikejiri B, Oldfield EH, Unnisa Ali I. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas. Cancer Res 1992;52:6716-21
8. Chung RY, Whaley J, Kley N, et al. TP53 mutation and 17p deletion in human astrocytomas. Genes Chromosom Cancer 1991;3: 323-31
9. von Deimling A, Louis DN, von Ammon K, Petersen I, Wiestler OD, Seizinger BR. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas and mixed gliomas. Cancer Res 1992;52:4277-79
10. Bello MJ, Vaquero J, de Campos JM, et al. Molecular analysis of chromosome 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumors. Int J Cancer 1994;57:172-75
11. Kraus JA, Koopmann J, Kaskel P, et al. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 1995; 54:91-95
12. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 1994;145:1175-90
13. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning, 2nd ed. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1989
14. Hart MN, Petito CK, Earle KM. Mixed gliomas. Cancer 1973;33: 134-40
15. Louis DN, von Deimling A, Seizinger BR. A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens. Am J Pathol 1992;141: 777-82
16. Bender B, Wiestler OD, von Deimling A. A device for processing large acrylamide gels. Biotechniques 1994;16:204-6
17. von Deimling A, Bender B, Louis DN, Wiestler OD. A rapid and non radioactive PCR based assay for the detection of allelic loss in human gliomas. Neuropathol Appl Neurobiol 1993;19:524-29
18. Wellenreuther R, Kraus J, Lenartz D, et al. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 1995;146:827-32
19. Shaw EG, Scheithauer BW, O-Fallon JR, Davis DH. Mixed oligoastrocytomas: A survival and prognostic factor analysis. Neurosurgery 1994;34:577-82
20. Rasheed BK, McLendon RE, Herndon JE, et al. Alterations of the TP53 gene in human gliomas. Cancer Res 1994;54:1324-30
21. Ohgaki H, Eibl RH, Schwab M, et al. Mutations in the p53 tumor suppressor gene in neoplasms of the human nervous system. Molecular Carcinogenesis 1993;8:74-80